Peeling skin disease (PSD) is an autosomal recessive skin disorder caused by mutations in CDSN and is characterized by superficial peeling of the upper epidermis.
Introduction
Peeling skin disease (PSD), a generalized inflammatory form of peeling skin syndrome, is an autosomal recessive skin disorder caused by mutations in CDSN and is characterized by superficial peeling of the upper epidermis (1, 2) . Patients with PDS have been reported to carry nonsense or frameshift mutations resulting in complete loss of expression of corneodesmosin (CDSN), a major component of corneodesmosomes that plays an important role in maintaining epidermis integrity. Herein, we report a patient with PDS caused by a novel homozygous large deletion in the 6p21.3 region encompassing CDSN.
Material and methods

Patient report
A 3-week-old Japanese girl from non-consanguineous parents was hospitalized for severe skin anomalies, hypereosinophilia (6,075/µL), and hypoproteinemia ( Fig. 1A-C ). Serum IgE levels were slightly elevated at 51 IU/L, and allergen-specific IgE were all negative. Thereafter the patient developed IgE-mediated fish allergy. She is now 16 years of age and has suffered from frequent episodes of widespread patchy peeling and erythema (Fig. 1D) . Serum IgE levels were significantly elevated (14,940 IU/L) with high allergen-specific IgE against multiple inhalant and food allergens with age: class 5 for house dust mite; class 4 for kiwi fruit; class 3 for caw's milk, egg white, shrimp, oyster, codfish and flounder; and class 2 for crab.
Mutation, array comparative genomic hybridization (CGH) and breakpoint analysis
DNA was extracted from blood samples using a standard method. The CDSN gene was amplified from genomic DNA using specific primers (2) . Array CGH and breakpoint analysis were performed as described previously (3) .
Results
The lack of expression of CDSN protein in her skin biopsy (Fig. 1E, F ) and amplification of any CDSN sequences from her DNA prompted us to perform array comparative genomic hybridization (CGH) analysis ( Fig. 2A ). We were able to clearly demonstrate a region of continuously reduced copy number around 6p21. 
Discussion
Repetitive Alu sequences are widely distributed and important for insertional mutagenesis and recombination events in a variety of human genetic disorders (4).
Unequal homologous recombination may occur between two Alu sequences oriented in the same direction, resulting in duplications, deletions and translocations. In fact, around 0.3% of all human genomic diseases have been reported to likely result from Alumediated unequal homologous recombination. However, in our patient, the two Alu sequences responsible for the deletion were oriented in opposite directions (Fig. 2B, C) .
Although Alu sequences inserted in the opposite directions have been found to be more prone to illegitimate recombination when they are less than 20 bp apart from each other Mutations in the CDSN gene in humans have been originally identified in patients with autosomal dominant hypotrichosis simplex of the scalp (HSS) (7) . To date, all mutations responsible for HSS have been reported to be heterozygous nonsense mutations, namely p.Gln200X, p.Gln209X, p.Gln215X and p.Tyr239X, all of which lead to truncated CDSN proteins. Aggregates formed by the dominant negative effect of mutated CDSN may be toxic to the hair follicle cells resulting in HSS (7) (8) (9) (10) . In contrast, genetic defects in patients with PDS have been shown to be homozygous nonsense (p.Lys59X) or frameshift mutations leading to complete loss of CDSN expression (2, (11) (12) (13) . Consistent with these findings, our patient carrying the homozygous deletion mutation exhibited no 6 protein expression of CDSN, and the parents and brother, who were heterozygous carrier (Fig. 2D) , did not show any abnormalities in the hair and skin. No products were amplified by the breakpoint PCR from 130 alleles of ethnically-matched healthy controls.
However, because of the non-consanguinity in the parents, genotyping studies using larger number of samples will be required to assess whether the deletion allele could have a significant frequency in the Japanese population.
In addition to CDSN, there were several other genes involved in the deletion in our patient: C6orf15, PSORS1C1, PSORS1C2, CCHCR1, and TCF19. Most of them have been reported to be associated with increased risk of psoriasis. However, the precise roles of these genes in psoriasis susceptibility, as well as their physiological roles, remain to be determined. It is also known that genetic variations of CCHCR1 are likely related to cervical epithelial cell transformation and nevirapine-induced rash in addition to psoriasis, none of which has been observed in our patient. On the other hand, no human disease has been reported to be associated with defective expression of these genes. Accordingly, our patient showed clinical features typical of PDS but no unexplained symptoms that could be related to other deleted genes.
Absence of CDSN protein leads to defects in the epidermal barrier, resulting in predisposition towards atopic dermatitis. Netherton syndrome is a rare dermatosis caused by mutations in SPINK5, encoding LEKTI, which is involved in the degradation of CDSN. Therefore, PDS, Netherton syndrome and atopic dermatitis may show clinical overlap between each other, especially in childhood. In fact, our patient was initially diagnosed with Netherton syndrome-like condition. Interestingly, marked eosinophilia was demonstrated at the onset in the patient, which probably resulted from the presence 7 of intense systemic allergic inflammation, i.e., severe atopic dermatitis. Serum IgE levels and allergen-specific IgE against multiple allergens increased dramatically with age.
These results further suggest the importance of maintaining skin barrier function in the environment to prevent the subsequent development of allergic diseases after birth.
In summary, our studies identified the novel homozygous large deletion encompassing CDSN as an additional type of mutation in PDS, and demonstrated its genomic mechanism to be Alu-mediated recombination. The skin biopsy specimens were stained with anti-corneodesmosin antibody (Atlas antibodies, Stockholm, Sweden). A specimen from a normal control showed positive staining in the granular layers (E), whereas corneodesmosin was not detectable in the patient's specimen (F). Bars indicate 100 µm for B and 50 µm for C, E and F. Amplified products were obtained from both PCR reactions for each DNA sample from the patient's father, mother and younger brother, indicating that they were heterozygous carriers. No amplified products were obtained from control DNA due to the absence of the deletion. Marker lanes contain 100-bp (top) and 1-kb (bottom) molecular size markers. 
